Skip to content
2000
Volume 14, Issue 3
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Thermal ablation is a minimally invasive therapeutic technique that has shown remarkable potential in treating unresectable tumors. However, clinical applications have stalled, due to safety ambiguities, slow heat induction, lengthy ablation times, and post-therapeutic monitoring issues. To further improve treatment efficacy, an assortment of micromaterials (e.g., nanoparticulates of gold, silica, or iron oxide and single-walled carbon nanotubes) are under study as thermal ablative adjuncts. In recent years, the micromaterial domain has become especially interesting. In vivo and in vitro animal studies have validated the use of microspheres as embolic agents in liver tumors, in advance of radiofrequency ablation. Microcapsules and microbubbles serving as ultrasound contrast and ablation sensibilizers are strong prospects for clinical applications. This review was conducted to explore benefits of the three aforementioned microscale technologies, in conjunction with tumor thermal ablation.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/1567201813666160108114208
2017-05-01
2025-05-21
Loading full text...

Full text loading...

/content/journals/cdd/10.2174/1567201813666160108114208
Loading

  • Article Type:
    Research Article
Keyword(s): Microbubble; microcapsule; microsphere; thermal ablation; tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test